NCT05234593|Completed
Loading search results
Sponsor study identifier
interventional
20
1 country
1
Study Start
August 1, 2022
Actual (reported)Primary Completion
February 2, 2023
Actual (reported)Study Completion
April 30, 2023
Actual (reported)The study aims to test the feasibility and acceptability of 1) consumption of EMPowerplus Lightning Sticks, 2) at-home collection of blood and urine samples, and 3) remote visits and completion of online behavioral questionnaires.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 19, 2022
Actual (reported)February 10, 2022
Actual (reported)August 1, 2022
Actual (reported)February 2, 2023
Actual (reported)April 30, 2023
Actual (reported)Feasibility measured by count of remaining Sticks
Feasibility will be determined if consumption of one Lightning Stick daily is achieved when greater than or equal to 80% of provided Sticks were taken. Measured by count of remaining (unused) Sticks.
week 6
Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale
Acceptability of taking the Lightning Sticks will be measure through 7 questions with a 6-point Likert-scale, (range: Strongly Disagree to Strongly Agree) Acceptability will be achieved if greater than or equal to 70% of children and parents report that taking powdered multinutrients is acceptable, at or above the Agree range.
week 6
Feasibility measured by count of participants who provide blood using the Tasso device
once, at baseline
Acceptability measured by a 'yes' response to their preference of using the Tasso device instead of a lab-based blood draw
once, at baseline
Feasibility measured by count of participants who provide the dried urine sample
once, at baseline
Acceptability measured by a 'yes' response to their preference of using the at-home dried urine sample collection method instead of a lab-based urine sample collection method
once, at baseline
Feasibility of remote study visits measured by count of participants who complete all online remote study visits
week 6
Feasibility and acceptability
multinutrient supplement containing vitamins, minerals, amino acids and antioxidants taken one Stick daily by dissolving the powder on or under the tongue
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Oregon Health & Science University
Portland, Oregon, 97239, United States
Jeanette Johnstone, PhD
Oregon Health and Science University
20 participants (actual enrollment reported by the registry).
First Submitted
January 19, 2022
First Posted
February 10, 2022
Study Start
August 1, 2022
Actual (reported)Cognitive-Behavioral Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in College Students - Study 1
Contact the study team to confirm eligibility.
Primary Completion
February 2, 2023
Actual (reported)Study Completion
April 30, 2023
Actual (reported)Last Updated
April 4, 2025
Record last verified: 2025-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: